Consumers’ Perception on Generic Medicines in Pampanga, Philippines

Abstract

Background The Philippines is one of the countries where only less than 30% of the population has regular access to essential medicines. When compared to other Asian countries with similar economic status, medicines are relatively more expensive, which resulted to the high out-of-pocket (OOP) expenditures (59%) among the marginalized sector according to WHO. For other households across all socioeconomic class, financial burden of medicine costs are likewise felt. This often leads to non-compliance to full treatment course, which could lead to more serious health implications. The use of generic medicines offers a good alternative to increase the patients’ compliance to treatment and lessen the OOP expenditures without compromising the safety and quality of care. Thus, it is important to conduct this study to know the consumers’ perceptions on the use of generic medicines. Methods This thesis examines the perception of consumers on generic medicines in the Philippines as well as other influencing factors affecting its uptake. Through a self-administered questionnaire, which was translated in Tagalog, respondents’ characteristics such as socio-demographic, general health profile, knowledge, awareness and perceptions on generic drugs were explored to know the association with the use of generics. Results This study reveals several important factors, including monthly income, residence, doctor’s prescription, government campaigns and other influencing factors affecting the use of generic medicines. Conclusion In general, consumers have positive attitude and acceptance towards generic medicines in the Philippines and their perceptions have improved over time. However, the findings in this study are not sufficient to represent the national prevalence of generics use in the country. It is therefore recommended that further study focusing on consumers’ perceptions should be conducted in a wider scale to come up with results on a nationwide view. The DOH should consider redesigning the policies, which will improve the knowledge and education not only of consumers but all the stakeholders regarding the significant role of generics in the healthcare system.